BlackRock’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.8K Hold
18,636
﹤0.01% 5275
2026
Q1
$39.5K Hold
18,636
﹤0.01% 5181
2025
Q4
$47K Hold
18,636
﹤0.01% 5069
2025
Q3
$52.7K Hold
18,636
﹤0.01% 4973
2025
Q2
$58.9K Buy
18,636
+1
+0% +$4 ﹤0.01% 4959
2025
Q1
$84.5K Hold
18,635
﹤0.01% 4811
2024
Q4
$44.7K Hold
18,635
﹤0.01% 4974
2024
Q3
$48.8K Hold
18,635
﹤0.01% 4819
2024
Q2
$65.6K Hold
18,635
﹤0.01% 4801
2024
Q1
$124K Sell
18,635
-78
-0.4% -$634 ﹤0.01% 4684
2023
Q4
$187K Sell
18,713
-58
-0.3% -$439 ﹤0.01% 4659
2023
Q3
$129K Sell
18,771
-1,011
-5% -$10K ﹤0.01% 4784
2023
Q2
$215K Sell
19,782
-3,006
-13% -$35.6K ﹤0.01% 4714
2023
Q1
$341K Buy
22,788
+47
+0.2% +$1.01K ﹤0.01% 4637
2022
Q4
$609K Sell
22,741
-178
-0.8% -$5.11K ﹤0.01% 4559
2022
Q3
$720K Sell
22,919
-124
-0.5% -$3.21K ﹤0.01% 4601
2022
Q2
$533K Buy
23,043
+52
+0.2% +$1.49K ﹤0.01% 4759
2022
Q1
$821K Buy
22,991
+177
+0.8% +$5.88K ﹤0.01% 4726
2021
Q4
$709K Buy
22,814
+1,337
+6% +$51.5K ﹤0.01% 4768
2021
Q3
$774K Buy
21,477
+1,762
+9% +$57.9K ﹤0.01% 4631
2021
Q2
$633K Sell
19,715
-7,830
-28% -$265K ﹤0.01% 4633
2021
Q1
$1.2M Buy
27,545
+1,291
+5% +$66.2K ﹤0.01% 4450
2020
Q4
$1.05M Buy
26,254
+397
+2% +$19.9K ﹤0.01% 4204
2020
Q3
$1.43M Sell
25,857
-106
-0.4% -$6.85K ﹤0.01% 3996
2020
Q2
$1.51M Buy
25,963
+25,158
+3,125% +$1.41M ﹤0.01% 3912
2020
Q1
$46K Buy
805
+71
+10% +$2.17K ﹤0.01% 4489
2019
Q4
$18K Buy
+734
New +$17.6K ﹤0.01% 4674
2019
Q3
Sell
-639
Closed -$14K 4975
2019
Q2
$14K Sell
639
-1,598
-71% -$30.7K ﹤0.01% 4725
2019
Q1
$45K Sell
2,237
-154
-6% -$3K ﹤0.01% 4492
2018
Q4
$33K Sell
2,391
-44
-2% -$989 ﹤0.01% 4526
2018
Q3
$70K Buy
2,435
+99
+4% +$2.97K ﹤0.01% 4505
2018
Q2
$72K Buy
+2,336
New +$70.9K ﹤0.01% 4511

Other funds holding BMRA

BlackRock's BMRA Position: Q2 2026 in Review

BlackRock held its Biomerica (BMRA) position steady in Q2 2026 at 18,636 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5275.

BlackRock first reported a position in BMRA in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.51M in Q2 2020. 15 funds tracked by Wall St. Rank hold BMRA as of Q2 2026.

  • BlackRock held 18,636 shares of Biomerica worth $32.8K as of Q2 2026.
  • BlackRock left its Biomerica share count unchanged in Q2 2026.
  • Biomerica made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5275 holding.
  • BlackRock first reported a position in Biomerica in Q2 2018 and has held it in 32 quarters since.
  • BlackRock's Biomerica position peaked at $1.51M in Q2 2020.
  • 15 funds tracked by Wall St. Rank held Biomerica as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.